We are pleased to advise all shareholders that through LOM’s engagement of Deloitte Corporate Finance Inc. (“Deloitte”) over the last several weeks, we will be sending a 3-page summary presentation and introduction of LOM’s Intellectual Property (“IP”) to a list of 30 of the world’s leading medical device and or syringe manufacturers.
A copy of this presentation is available for your review by way of the following link:
By engaging Deloitte, with offices in 50 countries around the world, and initiating contact with leading medical device manufacturers and vendors, we have commenced the important process to realize our goal of creating value for our investors by selling our IP for the best obtainable market price.
We are also pleased to report that many of these companies have expressed interest in our IP and are in various stages of discussion with us.
LOM is at an exciting stage of its history. The board and management will continue to work to maximize value for all shareholders and will keep you updated as events occur.
Should you have any questions, please contact us via the form on this page.
The Board of Directors